These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 3168396)

  • 1. Hæmochromatosis, with Diabetes Mellitus, Hepatic Cirrhosis and Chronic Ascites.
    Weber FP
    Proc R Soc Med; 1931 Feb; 24(4):478. PubMed ID: 19987976
    [No Abstract]   [Full Text] [Related]  

  • 2. Intense Ascites. ? Hepatic Syphilis.
    Clarke AV
    Proc R Soc Med; 1928 Oct; 21(12):1851-2. PubMed ID: 19986658
    [No Abstract]   [Full Text] [Related]  

  • 3. Exogenous adenosine 5'-triphosphate does not improve survival in rats with acute liver failure.
    Becker EP; Sun D; Minuk GY
    Dig Dis Sci; 2008 Mar; 53(3):794-8. PubMed ID: 17934848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin.
    Lay CS; May CM; Lee FY; Tsai YT; Lee SD; Chien S; Sinchon S
    World J Gastroenterol; 2006 Apr; 12(15):2351-6. PubMed ID: 16688824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.
    Merkel C; Bolognesi M; Angeli P; Finucci GF; Amodio P; Bellon S; Gatta A
    Br J Clin Pharmacol; 1990 Aug; 30(2):221-7. PubMed ID: 2206784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
    Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
    Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination].
    Sigusch H; Henschel L; Hoffmann A
    Gastroenterol J; 1991; 51(1):33-6. PubMed ID: 1910493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
    Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L
    Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
    Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ
    Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin.
    Barbare JC; Poupon R; Jaillon P; Bories P; Aussanaire M; Darnis F; Michel H; Cheymol G
    Hepatology; 1984; 4(1):59-62. PubMed ID: 6141135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide decreased liver metabolic activity in patients with hepatitis B surface antigen-positive cirrhosis.
    Lin HC; Tsai YT; Lee SD; Lee FY; Hsia HC; Meng HC; Wang SS; Lo KJ
    Clin Pharmacol Ther; 1992 Aug; 52(2):134-8. PubMed ID: 1354573
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.